Evaluating FEijoa foR DIabetes Prevention in a Multi-ethnic New ZeAlaND Cohort: the FERDINAND study. A community nutrition intervention in individuals with pre-diabetes.

Not Applicable

Recruiting

• Conditions: Prediabetes; Metabolic and Endocrine - Diabetes; Diet and Nutrition - Obesity

• Registration Number: ACTRN12622000210774
• Lead Sponsor: The university of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-07
• Last Update Posted: 16 October 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

•Male and female
•Caucasian (50%, n=80), Asian Chinese (12.5%, n=20), Asian Indian (12.5%, n=20) Maori (12.5%, n=20), Pacific (12.5%, n=20); self-reported, participant plus both parents
•Aged between 18 - 70 years
•Body mass index (BMI) 26 - 40 kg/m2
•Fasting plasma glucose (FPG) in prediabetic range, 5.6 – 6.9 mmol/L
•Otherwise healthy, as per self-report
•Agreement to participate in a weight loss study

Exclusion Criteria

•Type 1 or type 2 diabetes mellitus
•Medications controlling glycaemia
•Current or history of significant disease including cardiovascular disease; pancreatic disease, or other digestive diseases including inflammatory bowel syndrome/disease, ulcerative colitis, Crohn's disease; cancer; plus associated medications including steroids and atypical antipsychotics
•Recent body weight loss/gain > 10 % within previous 3 months or taking part in an active diet program; or current medications for weight loss; or intending to alter physical activity during following 12 months
•Previous bariatric surgery
•Smoker or vaper, current or in previous 6 months
•Recreational drug user, current or in previous 6 months
•Pregnant or breastfeeding women, current or in previous 6 months
•Dislike or unwilling to consume food items included in the study (including animal products), or hypersensitivities or allergies to these foods
•Unwilling/unable to comply with study protocol
•Participation in other clinical intervention study, current or in previous 6 months
•Considered unsuitable to participate by the PI

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measure change in fasting plasma glucose [In all participants at Baseline (month 0), month 2, month 4, month 8];Change in body weight (using digital scales)[In all participants at Baseline (month 0), month 2, month 4, month 8]